PMC:7105881 / 53517-53772
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1662 | 153-161 | Species | denotes | MERS-CoV | Tax:1335626 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T307 | 112-120 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T308 | 164-171 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T641 | 24-25 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T74554 | 112-120 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T62636 | 164-171 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T290 | 0-255 | Sentence | denotes | This may be potentially a consequence of the weak immunogenicity and/or protective efficacy of non-S structural proteins, further confirming the role of MERS-CoV S protein as the key target for the development of MERS vaccines, including subunit vaccines. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T872 | 50-64 | BV_15 | denotes | immunogenicity |
T873 | 153-161 | SP_9 | denotes | MERS-CoV |
T874 | 162-171 | PG_1 | denotes | S protein |
T875 | 213-217 | SP_9 | denotes | MERS |
T8643 | 50-64 | BV_15 | denotes | immunogenicity |
T62008 | 153-161 | SP_9 | denotes | MERS-CoV |
T23980 | 162-171 | PG_1 | denotes | S protein |
T68563 | 213-217 | SP_9 | denotes | MERS |